ftInvstr
UNIVPHOTO · Healthcare ₹490.6 +5.0% Mkt Cap ₹537 Cr

UNIVPHOTO

Healthcare Medical Devices
₹490.6
+5.0% today · 30d +2.21%
as of 2026-09-04
Price · Daily Candles
“UNIVPHOTO Plunges with -65.03% Revenue Drop, Yet Valuation Scores 'Cheap'”
UNIVPHOTO exhibits a mixed financial picture, with annual revenue plummeting -65.03% to ₹25 Cr and net profit at ₹87 Cr in 2025. Despite revenue contraction, the company holds a strong 'CHEAP' valuation score of 90 and a 'HIGH' profitability score of 80, alongside a 5.5x standalone TTM PE. The stock has seen a 29.26% gain in the last three months, trading at ₹437.85.
BULL CASE
+The company's 'HIGH' profitability score of 80 and a robust operating profit margin of 53.78% in Q4 2025 indicates efficient cost management.
+Despite declining revenue, UNIVPHOTO reported a net profit of ₹87 Cr in 2025, suggesting other income sources or prior period adjustments.
+The 'CHEAP' valuation score of 90, coupled with a Price-to-Book of 0.57, positions the stock favorably compared to its reported book value of ₹768.33.
+An ROCE of 10.0% is significantly higher than sector peers FISCHER (1.22%) and NURECA (2.48%).
+Current FCF of ₹185 Cr gives a substantial FCF yield of 38.56%.
BEAR CASE
Revenue witnessed a sharp decline of -65.03% YoY in 2025 to ₹25 Cr, indicating significant business contraction.
Quarterly revenue in Q4 2025 decreased by -20.0% YoY to ₹4 Cr, signaling continued operational challenges.
The trailing twelve-month EPS is negative at -₹80.34, impacting earnings quality.
ML prediction for FCF shows 'weak' ranks across all horizons (recent 2yr: 0.29, rolling 4yr: 0.227, stable 7yr: 0.233).
Overall growth is rated 'DECLINING' with a score of 26, reflecting persistent headwinds.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹5 Cr
+10.26% YoY
NET PROFIT
₹45 Cr
OPM
63.78%
-1.79pp YoY
EPS
₹41.41
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-50.0%, h2=-50.0%, h3=-50.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
UNIVPHOTO, with its 5.5x PE and 10.0% ROCE, appears undervalued compared to sector peers like FISCHER (1646.83x PE, 1.22% ROCE) and NURECA (318.96x PE, 2.48% ROCE).
PEERPEROCE %
UNIVPHOTO10.0
FISCHER1646.831.22
NURECA318.962.48
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
73
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation
Growth DECLINING 20
Profitability HIGH 80
Technicals STRONG 73
Risk LOW 90
Key Stats
P/B
0.57
52W HIGH
₹515.8
OFF HIGH
-4.89%
MKT CAP
₹537 Cr
◉ Active Signals
MACDBullish0.2142
RSI(14)Bullish63.46
Near 52W HighBullish-4.89
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold UNIVPHOTO and at what entry.

Sign up freeSign in